Aurora Innovation, Inc.
AUR Nasdaq Services-Computer Integrated Systems Design Financials FY2019βFY2025
What Aurora Innovation, Inc. does
No business description yet.
- Legal name
- Aurora Innovation, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 11, 2026
- Accession Β· CIK
- 0001828108-26-000016
0001828108
Revenue and margins
Aurora Innovation, Inc. had $3.0M of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$612M in fiscal 2025, β20,400.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Aurora Innovation, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 13.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Aurora Innovation, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.6B | $1.1B | $501M | $211M | $221M |
| Current ratio | 18.4x | 13.5x | 11.0x | 11.9x | 11.9x |
| Quick ratio | 18.4x | 13.5x | 11.0x | 11.9x | 11.9x |
| Total assets | $3.7B | $2.0B | $2.2B | $2.1B | $2.3B |
| Total liabilities | $348M | $217M | $250M | $263M | $203M |
| Shareholders' equity | $3.3B | $1.8B | $2.0B | $1.9B | $2.1B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 7 | 2 / 7 | 2 / 7 | 3 / 7 | 3 / 7 |
| Accruals ratio | β | β3.6% | β8.9% | β42.7% | β9.3% | β6.3% | β10.5% |
| Altman Z'' | β | β0.60 | 10.61 | 1.22 | 3.81 | 1.90 | 4.66 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $19.6M | $0.0M | $82.0M | $68.0M | $0.0M | $0.0M | $3.0M |
| Gross profit | β | β | β | β | $0.0M | $0.0M | β$14.0M |
| Research and development | $107M | $179M | $697M | $677M | $716M | $676M | $745M |
| Operating income | β$114M | β$218M | β$731M | β$1.9B | β$835M | β$786M | β$901M |
| Pretax income | β$102M | β$214M | β$760M | β$1.7B | β$796M | β$748M | β$816M |
| Income tax | β$7.8M | $0.0M | β$5.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$94.1M | β$214M | β$755M | β$1.7B | β$796M | β$748M | β$816M |
| Diluted EPS | β$0.37 | β$0.79 | β$1.22 | β$1.51 | β$0.60 | β$0.46 | β$0.44 |
| Diluted shares | 0.25B | 0.27B | 0.62B | 1.14B | 1.33B | 1.62B | 1.84B |
| Cash flow | |||||||
| Cash from operations | β$94.7M | β$192M | β$564M | β$508M | β$598M | β$611M | β$581M |
| Capital expenditure | $3.8M | $7.0M | $48.0M | $15.0M | $15.0M | $34.0M | $31.0M |
| Free cash flow | β$98.6M | β$199M | β$612M | β$523M | β$613M | β$645M | β$612M |
| Depreciation and amortization | $1.8M | $3.0M | $16.0M | $22.0M | $21.0M | $21.0M | $30.0M |
| Stock-based compensation | $28.1M | $17.0M | $220M | $156M | $160M | $144M | $188M |
| Acquisitions | $23.1M | $0.0M | β$294M | $0.0M | $0.0M | β | β |
| Share buybacks | β | β | $755M | β | β | β | β |
| Dividends and buybacks | β | β | $755M | β | β | β | β |
| Balance sheet | |||||||
| Cash and short-term investments | $246M | $387M | $1.6B | $1.1B | $501M | $211M | $221M |
| Current assets | β | $406M | $1.7B | $1.1B | $1.2B | $1.3B | $1.3B |
| Current liabilities | β | $32.0M | $91.0M | $83.0M | $111M | $105M | $111M |
| Property and equipment, net | β | $10.9M | $94.0M | $91.0M | $94.0M | $104M | $103M |
| Goodwill | β | $30.0M | $1.1B | $0.0M | $0.0M | $0.0M | β |
| Intangible assets | β | $52.7M | $617M | $618M | $617M | $617M | $617M |
| Total assets | β | $619M | $3.7B | $2.0B | $2.2B | $2.1B | $2.3B |
| Total liabilities | β | $132M | $348M | $217M | $250M | $263M | $203M |
| Shareholders' equity | β$83.0M | β$277M | $3.3B | $1.8B | $2.0B | $1.9B | $2.1B |
| Margins | |||||||
| Gross margin | β | β | β | β | β | β | β466.7% |
| Operating margin | β579.1% | β | β891.5% | β2,723.5% | β | β | β30,033.3% |
| EBITDA margin | β569.8% | β | β872.0% | β2,691.2% | β | β | β29,033.3% |
| Net margin | β480.0% | β | β920.7% | β2,533.8% | β | β | β27,200.0% |
| FCF margin | β502.8% | β | β746.3% | β769.1% | β | β | β20,400.0% |
| Returns | |||||||
| Return on capital employed | β | β37.1% | β20.3% | β96.6% | β39.3% | β38.7% | β40.4% |
| Return on equity | β | β | β49.3% | β67.2% | β42.2% | β38.8% | β40.6% |
| Return on assets | β | β34.6% | β35.0% | β60.6% | β37.6% | β34.2% | β36.4% |
| Return on tangible equity | β | β | β46.9% | β147.8% | β58.2% | β59.5% | β53.6% |
| Growth | |||||||
| Revenue growth | β | β100.0% | β | β17.1% | β100.0% | β | β |
| Share count change | β | 6.5% | 129.2% | 84.1% | 16.1% | 21.9% | 13.7% |
| Financial health | |||||||
| Current ratio | β | 12.7x | 18.4x | 13.5x | 11.0x | 11.9x | 11.9x |
| Quick ratio | β | 12.7x | 18.4x | 13.5x | 11.0x | 11.9x | 11.9x |
| Capital allocation | |||||||
| Capex / revenue | 19.5% | β | 58.5% | 22.1% | β | β | 1,033.3% |
| Stock comp / revenue | 143.5% | β | 268.3% | 229.4% | β | β | 6,266.7% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 4.0 | 2.0 | 2.0 | 3.0 | 3.0 |
| Altman Z'' | β | β0.6 | 10.6 | 1.2 | 3.8 | 1.9 | 4.7 |
| Accruals ratio | β | β3.6% | β8.9% | β42.7% | β9.3% | β6.3% | β10.5% |
Source: SEC EDGAR XBRL filings (CIK 0001828108). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.